Author:
Shitara Kohei,Chin Keisho,Yoshikawa Takaki,Katai Hitoshi,Terashima Masanori,Ito Seiji,Hirao Motohiro,Yoshida Kazuhiro,Oki Eiji,Sasako Mitsuru,Emi Yasunori,Tsujinaka Toshimasa
Funder
Yakult Honsha
Chugai Pharmaceutical
Ono Pharmaceutical
MSD
Eli Lilly
Novartis Pharma
Covidien
Daiichi-Sankyo
Nihon Kayaku
Taiho Pharmaceutical
Abbott
Takeda Pharmaceutical Company
Johnson and Johnson
Kaken Pharmaceutical
Secom Medical Systems
Pfizer
Bristol-Myers Squibb
Kyowa Hakko Kirin
Sanofi
La Roche
Merck Serono
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Gastroenterology,Oncology,General Medicine
Reference11 articles.
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0. Cancer Incidence Mortality Worldwide. IARC CancerBase. 2012. http://globocan.iarc.fr/default.aspx . Accessed 4 April 2015.
2. Ministry of Health, Labour and Welfare. Summary of vital statistics 2013. http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei13/dl/11_h7.pdf . Accessed 4 Apr 2015.
3. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines (ver. 4). Tokyo: Kanehara publication. 2014.
4. Shirasaka T. Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas. Jpn J Clin Oncol. 2009;39:2–15.
5. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献